Suggestions for points to stress in your letter are attached. Sincerely, Patricia B. Lieberman, Ph.D. Senior Science Policy Fellow Points to make in your letter to the FDA on quantitative caffeine labeling. The FDA advises pregnant women to avoid caffeine, or consume it only sparingly. Caffeine reduces the chance of getting pregnant. One study showed that the chances of taking more than a year to conceive are nearly five-times higher in women who consume more than 100 mg of caffeine per day than for women who drink less.
Caffeine increases the risk of miscarriage.
Low birth weight increases a baby's risk of illness and death. Caffeine exacerbates the low calcium intakes of American women and teenagers, and increases the risk of osteoporosis. American children are consuming more soft drinks than ever, and many of them contain caffeine. Soft drink consumption has the largest impact on adequacy of calcium in the diets of American children. Caffeine causes adverse behavioral effects, such as restlessness, addiction, anxiety, and sleeplessness.